1. Home
  2. TRDA vs LOVE Comparison

TRDA vs LOVE Comparison

Compare TRDA & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$6.97

Market Cap

274.5M

Sector

Health Care

ML Signal

HOLD

Logo The Lovesac Company

LOVE

The Lovesac Company

HOLD

Current Price

$13.78

Market Cap

227.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
LOVE
Founded
2016
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
274.5M
227.3M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
TRDA
LOVE
Price
$6.97
$13.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$21.00
$25.00
AVG Volume (30 Days)
252.6K
181.4K
Earning Date
05-08-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,421,000.00
$697,115,000.00
Revenue This Year
$39.97
$4.63
Revenue Next Year
$50.80
$6.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.42
52 Week Low
$4.93
$10.33
52 Week High
$16.45
$20.88

Technical Indicators

Market Signals
Indicator
TRDA
LOVE
Relative Strength Index (RSI) 45.70 35.48
Support Level $5.75 $11.00
Resistance Level $7.02 $15.59
Average True Range (ATR) 0.47 0.94
MACD 0.27 -0.26
Stochastic Oscillator 72.36 7.76

Price Performance

Historical Comparison
TRDA
LOVE

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

Share on Social Networks: